Peginterferon alfa and ribavirin for the treatment of chronic hepatitis C

  • Technology appraisal guidance
  • TA200
  • Published: 
Download guidance (PDF)

Update information

Minor changes since publication

February 2014: The implementation section was updated to clarify that peginterferon alfa and ribavirin is recommended as an option for treating chronic hepatitis C. Additional minor maintenance was also carried out.

March 2012: Minor maintenance.

ISBN: 978-1-4731-5634-0